Bio-Techne Corporation
TECH
Ранг среди акций
#1869
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures,... Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Цена акции
$72.50
Рыночная капитализация
$11.37B
Изменение (1 день)
-0.10%
Изменение (1 год)
17.20%
Страна
US
Торговля Bio-Techne Corporation (TECH)
Категория
Healthcare
История дивидендной доходности для Bio-Techne Corporation (TECH)
Дивидендная доходность (TTM) компании Bio-Techne Corporation (тикер: TECH) на 2024-06-30 составляет: 0.45%
Средняя дивидендная доходность за последние 5 лет: 0.42%
Средняя дивидендная доходность за последние 5 лет: 0.42%
История дивидендной доходности компании Bio-Techne Corporation (TECH) с 2000 по 2026
Дивидендная доходность на конец каждого года (TTM)
| Год | Дивидендная доходность | Изменить |
|---|---|---|
| 2026 (TTM) | 0.44% | -29.03% |
| 2025 | 0.62% | 37.78% |
| 2024 | 0.45% | 15.38% |
| 2023 | 0.39% | 5.41% |
| 2022 | 0.37% | 32.14% |
| 2021 | 0.28% | -41.67% |
| 2020 | 0.48% | -21.31% |
| 2019 | 0.61% | -29.89% |
| 2018 | 0.87% | -19.44% |
| 2017 | 1.08% | -5.26% |
| 2016 | 1.14% | -11.63% |
| 2015 | 1.29% | -3.01% |
| 2014 | 1.33% | -21.30% |
| 2013 | 1.69% | 12.67% |
| 2012 | 1.50% | 17.19% |
| 2011 | 1.28% | -28.49% |
| 2010 | 1.79% | 52.99% |
| 2009 | 1.17% | 0.00% |
| 2008 | 0.00% | 0.00% |
| 2007 | 0.00% | 0.00% |
| 2006 | 0.00% | 0.00% |
| 2005 | 0.00% | 0.00% |
| 2004 | 0.00% | 0.00% |
| 2003 | 0.00% | 0.00% |
| 2002 | 0.00% | 0.00% |
| 2001 | 0.00% | 0.00% |
| 2000 | 0.00% | 0.00% |
Дивидендная доходность (TTM) аналогичных компаний или конкурентов
| Компания | Дивидендная доходность | Страна |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.17% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
